On May 2, 2023, Stryker Corporation completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage, medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. Follow the Stryker Neurovascular LinkedIn page for the latest on Cerus Endovascular products. Cerus Endovascular is engaged in the novel design and manufacturing of innovative intra-saccular technologies for the Neurovascular market place.
